• Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCH

  • 2024/07/30
  • 再生時間: 31 分
  • ポッドキャスト

Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCH

  • サマリー

  • In this episode of Trends from the Trenches, host Stan Gloss speaks with Howard Jacob, vice president of genomics research at AbbVie. They discuss Jacob’s beginnings at AbbVie, data siloing and “my data vs. our data” issues, and the role of funding in plan execution and leadership support. Jacob also delves into the origins of the AbbVie R&D Convergence Hub (ARCH—winner of a 2023 Bio-IT World Innovative Practices Award), how they secured a sizable investment for its development, leveraging ARCH for rare diseases, and the strategy behind disseminating info that was generated by ARCH.

    Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

In this episode of Trends from the Trenches, host Stan Gloss speaks with Howard Jacob, vice president of genomics research at AbbVie. They discuss Jacob’s beginnings at AbbVie, data siloing and “my data vs. our data” issues, and the role of funding in plan execution and leadership support. Jacob also delves into the origins of the AbbVie R&D Convergence Hub (ARCH—winner of a 2023 Bio-IT World Innovative Practices Award), how they secured a sizable investment for its development, leveraging ARCH for rare diseases, and the strategy behind disseminating info that was generated by ARCH.

Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.

Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCHに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。